Multiple Klebsiella pneumoniae KPC Clones Contribute to an Extended Hospital Outbreak by C. Ferrari et al.
fmicb-10-02767 November 29, 2019 Time: 16:45 # 1
ORIGINAL RESEARCH
published: 29 November 2019
doi: 10.3389/fmicb.2019.02767
Edited by:
Rustam Aminov,
University of Aberdeen,
United Kingdom
Reviewed by:
Costas C. Papagiannitsis,
University of Thessaly, Greece
Philippe Glaser,
Institut Pasteur, France
Marco Maria D’Andrea,
University of Rome Tor Vergata, Italy
*Correspondence:
Davide Sassera
davide.sassera@unipv.it
Specialty section:
This article was submitted to
Antimicrobials, Resistance
and Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 12 June 2019
Accepted: 13 November 2019
Published: 29 November 2019
Citation:
Ferrari C, Corbella M, Gaiarsa S,
Comandatore F, Scaltriti E, Bandi C,
Cambieri P, Marone P and Sassera D
(2019) Multiple Klebsiella pneumoniae
KPC Clones Contribute to an
Extended Hospital Outbreak.
Front. Microbiol. 10:2767.
doi: 10.3389/fmicb.2019.02767
Multiple Klebsiella pneumoniae KPC
Clones Contribute to an Extended
Hospital Outbreak
Carolina Ferrari1, Marta Corbella1,2, Stefano Gaiarsa1, Francesco Comandatore3,4,
Erika Scaltriti5, Claudio Bandi3,6, Patrizia Cambieri1, Piero Marone1 and
Davide Sassera7*
1 Microbiology and Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 2 Biometric and Medical Statistics
Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 3 Pediatric Research Center Romeo ed Enrica Invernizzi,
University of Milan, Milan, Italy, 4 Department of Biomedical and Clinical Sciences “L. Sacco”, University of Milan, Milan, Italy,
5 Risk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna
(IZSLER), Brescia, Italy, 6 Department of Biosciences, University of Milan, Milan, Italy, 7 Department of Biology
and Biotechnology “L. Spallanzani”, University of Pavia, Pavia, Italy
The circulation of carbapenem-resistant Klebsiella pneumoniae (CRKP) is a significant
problem worldwide. In this work we characterize the isolates and reconstruct the spread
of a multi-clone epidemic event that occurred in an Intensive Care Unit in a hospital
in Northern Italy. The event took place from August 2015 to May 2016 and involved
23 patients. Twelve of these patients were colonized by CRKP at the gastrointestinal
level, while the other 11 were infected in various body districts. We retrospectively
collected data on the inpatients and characterized a subset of the CRKP isolates
using antibiotic resistance profiling and whole genome sequencing. A SNP-based
phylogenetic approach was used to depict the evolutionary context of the obtained
genomes, showing that 26 of the 32 isolates belong to three genome clusters, while
the remaining six were classified as sporadic. The first genome cluster was composed
of multi-resistant isolates of sequence type (ST) 512. Among those, two were resistant
to colistin, one of which indicating the insurgence of resistance during an infection. One
patient hospitalized in this period was colonized by two strains of CRKP, both carrying
the blaKPC gene (variant KPC-3). The analysis of the genome contig containing the
blaKPC locus indicates that the gene was not transmitted between the two isolates.
The second infection cluster comprised four other genomes of ST512, while the third
one (ST258) colonized 12 patients, causing five clinical infections and resulting in seven
deaths. This cluster presented the highest level of antibiotic resistance, including colistin
resistance in all 17 analyzed isolates. The three outbreaking clones did not present
more virulence genes than the sporadic isolates and had different patterns of antibiotic
resistance, however, were clearly distinct from the sporadic ones in terms of infection
status, being the only ones causing overt infections.
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Frontiers in Microbiology | www.frontiersin.org 1 November 2019 | Volume 10 | Article 2767
fmicb-10-02767 November 29, 2019 Time: 16:45 # 2
Ferrari et al. Prolonged Multiclone Outbreak of KPC K. pneumoniae
INTRODUCTION
Klebsiella pneumoniae (Kp) is ubiquitous in the environment,
part of the normal intestinal microbiota in humans and capable
of colonizing the skin and nasopharynx of healthy individuals
(Podschun and Ullmann, 1998; Broberg et al., 2014). Kp can
persist on abiotic surfaces of different origin through the
synthesis of biofilm, which can also make bacteria resistant to
the action of antimicrobial agents (Di Martino et al., 2003). In
immunocompromised or debilitated hospitalized patients with
severe underlying diseases, Kp causes urinary tract, respiratory
tract and bloodstream infections (Podschun and Ullmann, 1998)
as well as other less frequent diseases, including osteomyelitis,
arthritis (Ghorashi et al., 2011), and meningitis (Ko et al., 2002;
Tumbarello et al., 2006; Nordmann et al., 2009). Kp is responsible
for roughly 12% of Gram-negative infections in hospital intensive
care units (ICUs) in Europe (European Centre for Disease
Prevention and Control [ECDC], 2016). Kp invasive infections
are associated with high rates of morbidity and mortality due to
the high prevalence of resistance to most available antimicrobial
agents (Patel et al., 2008; Borer et al., 2009). This is an emerging
concern in clinical care resulting in an increase of mortality
rates and costs.
The most commonly used class of antibiotics against
nosocomial infections is β-lactams, which includes penicillin
derivatives, cephalosporins, monobactams and the most recently
developed carbapenems. Frequent use and abuse of these drugs,
combined with the transmissibility of resistance determinants
mediated by mobile elements (plasmids, transposons, and other
integrative conjugative elements), has contributed to the spread
of resistance to β-lactams by Kp (Mathers et al., 2015; Navon-
Venezia et al., 2017). In the last 20 years, the emergence of
isolates resistant to carbapenems has limited the efficacy of this
last line treatment option hampering the use of this whole class
of antibiotics, with few alternatives (Mathers et al., 2015; Navon-
Venezia et al., 2017). One of the most common mechanism
of resistance to carbapenems in Kp is the K. pneumoniae
carbapenemase (KPC). This is an Ambler molecular class A
serine enzyme that is able to hydrolyze a broad variety of
β-lactams. KPC carbapenemases are plasmid-encoded, they have
been originally associated with the Kp clonal group 258 (CG258)
(Samuelsen et al., 2009; Breurec et al., 2013) but are not limited
to it, as a number of occurrences of strains of other sequence
types (ST) carrying the gene have been reported (Giakkoupi
et al., 2010; Qi et al., 2010; Tzouvelekis et al., 2013; Markovska
et al., 2015; Oteo et al., 2016; Villa et al., 2016; Wei et al.,
2016; Aires et al., 2017). KPC-carrying Kp strains have recently
spread worldwide, with some countries, including Italy, being
heavily affected. In Italy, in 2017, 33.9% of the Kp nosocomial
infections were caused by KPC strains (Sabbatucci et al., 2017).
Most of these strains belong to the CG258, which in Italy has
been shown to have been imported on four occasions, giving
rise to four Italian-subclades (Gaiarsa et al., 2015). The spread
of carbapenem-resistant strains has led to the resurgence of the
use of colistin, previously abandoned due to its nephrotoxicity
and neurotoxicity (Javan et al., 2015; Velkov et al., 2018). This
has however resulted in the emergence of colistin-resistant
strains, both due to the insurgence of chromosomal mutations
(Cannatelli et al., 2014; Olaitan et al., 2014) and to the acquisition
of plasmid-encoded resistance genes (Di Pilato et al., 2016;
Liu et al., 2016).
Whole genome sequencing (WGS) of bacterial isolates is
increasingly used for epidemiological investigations (Sabat et al.,
2013). The use of genomics in clinical settings as a routine tool
could in the future be an important aid to the microbiologist
to accurately identify and characterize outbreaks at early stages,
and to identify transmission routes. However, only from the
combination of typing data with clinical and demographic data
the correct interpretation of the origin and evolution of an
outbreak can be obtained (Van Belkum et al., 2007).
The present retrospective study analyzes a nosocomial
outbreak, lasting 10 months (August 2015 – May 2016), caused
by K. pneumoniae KPC, in an ICU and the period immediately
before and after, for a total of 12 months. Thanks to the
combination of genomic, microbiological and clinical data it was
possible to reconstruct the epidemic event and to characterize
the multiple unrelated strains that spread in mostly temporally
non-overlapping periods.
THE EVENT
At the Fondazione IRCCS Policlinico San Matteo in Pavia, a 900-
bed hospital in Northern Italy, cardio-respiratory patients are
admitted to a specific Cardiorespiratory ICU where preoperative
assessment, anesthetic treatment and intensive post-operative
treatment of the patients undergoing cardiac and thoracic surgery
are performed. This ICU has eight beds and is managed by 37 staff
members. All ICU patients are subjected to surveillance through
rectal swab at admission and once a week during the stay in the
ward, to monitor for carbapenem-resistant Enterobacteriaceae
colonization. In case of positivity, additional contact precautions
are applied, which are interrupted only after three consecutive
negative surveillance samples and are resumed in case of a single
new positive screening swab.
Retrospectively, an increase in the number of carbapenem-
resistant Klebsiella pneumoniae (CRKP) colonizations and
infections in the ICU was observed in the period from August
2015 to May 2016. The first infection was reported on 15th
August 2015. After this event, the number of infected and
colonized patients gradually increased and peaked twice, in
December 2015 and March 2016. When the first increase in cases
was detected (December 2015), additional surveillance measures
were undertaken: increase in the training of health personnel and
in the use of disposable devices, more accurate daily cleaning, and
increased passive surveillance. Environmental screenings were
performed in the ward after the second peak in cases in March
2016, all resulting negative. No cohorting or spatial isolation
of individual patients were applied. The situation returned to
the norm, with no clinical infections, in June 2016 (Figure 1).
The period from June 2015 to May 2016 was thus analyzed
to understand the characteristics of the observed prolonged
outbreak. A total of 426 patients were hospitalized in the ICU
during that period and the procedure for rectal swab screening
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FIGURE 1 | Number of samples positive for carbapenem-resistant Klebsiella
pneumoniae from patients hospitalized in the ICU during the August 2015 –
May 2016 period. Samples positive for rectal swab screening are colored in
blue; samples showing positive infection are colored in orange.
for Carbapenem-Resistant Enterobacteriaceae identified 23/426
CRKP-colonized patients (average age: 61.1 years; range: 27–
80 years). Out of these 23 patients, 18 were negative at the
admission time into the ICU. Two of the five patients (numbers
6 and 22) that were positive at admission at the ICU were
previously hospitalized in other wards (respectively another
ICU and Cardiac Surgery) were they became colonized. The
remaining three patients (numbers 2, 4, and 7) were positive
at the first swab, suggesting positivity before hospitalization.
During the event 11/23 (47.8%) patients died, 2/23 (8.7%)
were discharged for rehabilitation and 10/23 (43.5%) were
transferred to other hospitalization facilities or hospital wards.
Eleven of these 23 (47.8%) patients developed overt infections,
with CRKP isolated from blood, respiratory tract, urine and
wounds. Seven of the 11 infected patients died while at the
ICU. The demographic and hospitalization characteristics of
the 23 patients are reported in Table 1. During the same
period, a total of eight other patients resulted infected by
non-carbapenem resistant Kp, thus 58% of total Kp infections
were CRKP.
MATERIALS AND METHODS
Ethics Statement
The study was designed and conducted in accordance with the
Helsinki declaration and approved by the Ethics Committee of
Fondazione IRCCS Policlinico San Matteo in Pavia, Italy.
Bacterial Strain Identification and
Susceptibility Testing
During the entirety of the event, all surveillance rectal swabs
were sent to the Microbiology and Virology Unit and were
directly plated on chromID CARBA Agar (BioMérieux,
Marcy-l’Étoile, France) to screen for the presence of
carbapenemase-producing Enterobacteriaceae. In the same
period, all clinical specimens (blood samples, bronchial
aspirates, bronchoalveolar wash, urine samples, and wound
swabs) were all cultured in parallel on all the following
media: Columbia Blood Agar with 5% sheep blood, chocolate
agar, selective media or on Schaedler agar and 5% sheep
blood (BioMérieux SA, Marcy-l’Étoile, France) anaerobically
and incubated at 37◦C overnight. Colonies suspected to be
Kp based on morphology were identified with the MALDI
Biotyper 3.1 system based on Matrix-Assisted Laser Desorption
Ionization time-of-flight (MALDI-TOF) (Bruker Daltonics,
Bremen, Germany).
We selected a subset of the Kp isolates from surveillance
and clinical samples based on sample type, collection date
and resistance profile, to perform additional characterization.
Antibiotic susceptibility testing and minimum inhibitory
concentrations (MICs) determinations were performed using
the BD Phoenix 100 automated system (Becton, Dickinson and
Company, Franklin Lakes, NJ, United States) and interpreted
following the clinical breakpoints of the version 6.0 of the
European Committee on Antimicrobial Susceptibility Testing
[EUCAST] (2016)1. Tigecycline and carbapenems MICs
were confirmed by E-test strips (BioMérieux, Marcy-l’Étoile,
France). As recommended by European Committee on
Antimicrobial Susceptibility Testing [EUCAST] (2016)2 and
the European Centre for Disease Prevention and Control
[ECDC] (2016)3, colistin MICs were confirmed performing
the broth microdiluition (MIC-Strip Colistin (MERLIN
Diagnostika GmbH, Germany).
DNA Extraction and Genome Sequencing
Total DNA extraction was performed for the selected isolates
using the QIAamp DNA mini kit (Qiagen, Italy) according
to manufacturer’s instructions. DNA was sequenced using
the Illumina MiSeq platform (Illumina Inc., San Diego, CA,
United States), with paired-end runs of 2× 250 bp, after Nextera
XT library preparation.
Genomic Analyses
Sequencing reads were quality checked using FastQC4 and
trimmed using the Trimmomatic software (Bolger et al., 2014).
SPAdes-3.10.1 (Bankevich et al., 2012) was then used to assemble
the pair-end reads using the accurate setting. Multilocus sequence
typing (MLST) profiles and virulence/resistance gene variants
were determined in silico using the Kleborate tool5. Presence of
the mcr gene was tested using ResFinder Version 3.1.0 (database
updated to February 20, 2019) (Zankari et al., 2012). Plasmid
content was characterized using PlasmidFinder Version 2.0.1
(database updated to November 20, 2018) (Carattoli et al.,
2014), while the contigs containing the blaKPC gene were
1http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_
tables/v_6.0_Breakpoint_table.xls
2http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/General_
documents/Recommendations_for_MIC_determination_of_colistin_March_
2016.pdf
3https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/
enterobacteriaceae-risk-assessment-diseases-caused-by-antimicrobial-resistant-
microorganisms-europe-june-2016.pdf
4www.bioinformatics.babraham.ac.uk/projects/fastqc/
5https://github.com/katholt/Kleborate
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TABLE 1 | Table showing the hospitalization characteristics of all patients admitted to the ICU in the examined period that resulted positive to carbapenem-resistant
Klebsiella pneumoniae at least once.
Patient number Admission date Discharge date Sample number Outcome
Surveillance Clinical
1 May 24, 2015 June 17, 2015 3 0 Transfer to another hospital ward
2 June 17, 2015 June 23, 2015 2 0 Transfer to another hospital ward
3 July 31, 2015 September 16, 2015 13 1 Death
4 June 29, 2015 June 30, 2015 2 0 Transfer to another hospital ward
5 August 21, 2015 March 04, 2016 28 15 Death
6 July 11, 2015 September 18, 2015 1 1 Transfer to another hospital ward
7 October 08, 2015 October 23, 2015 3 1 Transfer to another hospital ward
8 October 14, 2015 November 17, 2015 6 2 Death
9 October 22, 2015 December 28, 2015 10 0 Death
10 October 31, 2015 December 17, 2015 7 0 Discharge for rehabilitation
11 November 24, 2015 December 03, 2015 2 0 Transfer to another hospital ward
12 November 26, 2015 December 31, 2015 9 4 Death
13 December 30, 2015 January 25, 2016 4 1 Transfer to another hospital ward
14 January 07, 2016 February 12, 2016 6 0 Death
15 January 08, 2016 May 06, 2016 17 2 Death
16 January 15, 2016 March 22, 2016 11 10 Death
17 January 22, 2016 March 21, 2016 8 0 Death
18 February 06, 2016 March 20, 2016 6 0 Death
19 February 26, 2016 April 03, 2016 6 8 Death
20 March 01, 2016 March 15,2016 3 0 Transfer to another hospital ward
21 March 31, 2016 May 25, 2016 5 1 Discharge for rehabilitation
22 April 04, 2016 April 08, 2016 1 0 Transfer to another hospital ward
23 April 11, 2016 April 26, 2016 3 0 Transfer to another hospital ward
compared using the BLASTn and the Mauve software (Darling
et al., 2010) and subjected to Maximum Likelihood phylogeny
using RAxML (Stamatakis, 2014) with the GAMMA substitution
model, considering the Ascertainment bias and applying the
Lewis correction (Lewis, 2001). The tree topology reliability was
tested using 100 bootstrap replicates.
To estimate genomic variability, the obtained genome
sequences were added to a selected dataset of K. pneumoniae
genomes extracted from the PATRIC database (Wattam et al.,
2016). PATRIC genomes were selected, using an in-house script,
to be the closest in genomic distance to our strains. In detail, each
genome was compared to all PATRIC database genomes using
Mash (Ondov et al., 2016) and the 50 best hits were selected. All
the obtained best hits lists were merged removing duplication, to
obtain the final genomic dataset. CoreSNPs were extracted from
the resulting dataset following a published method (Gaiarsa et al.,
2015). Briefly, the Mauve software (Darling et al., 2010) was used
to align all novel genomes and the similar PATRIC genomes to
a well-characterized complete genome reference [NZ_CP006923
(DeLeo et al., 2014)]. Individual alignments were merged using
a Python script to obtain a multi-alignment file, allowing to
extract coreSNPs (defined as variations of a single nucleotide
flanked on each side by two nucleotides conserved in all the
genomes analyzed).
The distribution of the coreSNPs distances among
strains was visualized using the software R Version 3.2.3
(R Core Team, 2013) and the coreSNP cut-off threshold was
determined manually by looking at the graph and finding that
there were two groups of genome pairs, those with less than
15 SNPs and those with more than 35 SNPs (Figure 2). The
distribution allowed us to safely infer that two genomes could
be considered as part of the same transmission cluster if their
distance in number of coreSNPs was lower than the 15 SNPs
threshold value. The coreSNPs alignment was used to perform
a phylogenetic analysis using the software RAxML (Stamatakis,
2014) with the GAMMA substitution model, considering
the Ascertainment bias and applying the Lewis correction
(Lewis, 2001). The tree topology reliability was tested using 100
bootstrap replicates.
The genomes of the epidemic clusters were investigated also
in order to detect possible unique genomic characteristics. A SNP
based phylogeny was generated for each cluster, using the same
approach as the global phylogeny, and adding to each cluster
the genome not part of the cluster that resulted the closest
in the global phylogeny. The phylogenies and the genomic
alignments of each cluster and their outgroup were used as inputs
for a recombination analysis with the software ClonalFrameML
(Didelot and Wilson, 2015). Furthermore, the presence and
abundance of Insertion Sequences (IS) was tested using the
software ISSeeker (Adams et al., 2016) against all IS retrieved
from the Issaga database (Varani et al., 2011) using “Klebsiella”
as organism keyword (on date July 17, 2019).
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FIGURE 2 | CoreSNPs distribution between genome pairs. Pairs of genomes
within a distance of 16 SNPs (SNPs threshold) were considered as part of the
same transmission cluster.
RESULTS
An outbreak of CRKP occurred in the cardio-respiratory ICU
from August 2015 to May 2016, involving 23 patients (12
colonized, 11 infected). In order to characterize the event,
we retrieved all the CRKP strains isolated during the event
and in the 2 months before. We obtained a total of 144
samples, 98/144 (68.1%) surveillance samples and 46/144 (31.9%)
clinical samples (16 blood cultures, 12 bronchial aspirates, 1
bronchoalveolar wash, 8 urines, and 9 wound swabs). A total
of 32/144 K. pneumoniae isolates, from 22 rectal swabs and
10 clinical specimens, were selected based on sample types
and collection date, including at least one per each of the 23
positive patients, for antibiotic resistance characterization and
genome sequencing (Table 2). The results of the antibiotic
susceptibility tests are reported in Supplementary Table S1
and show that all the isolates are resistant to at least
one carbapenem: 32/32 to Ertapenem, 31/32 to Meropenem,
29/32 to Imipenem. Moreover, 31 isolates are resistant to
aminoglycosides (25 to Amikacin, 22 to Gentamicin, 28 to
Tobramycin). Twenty isolates are resistant to Fosfomycin
(MICs > 64 mg/L), 20 to Colistin (MICs ranging from
4 to >64 mg/L) and three are resistant to Tigecycline
(MICs > 2 mg/L). Only one strain from a surveillance
sample (genome ID: 1880), resulted to be resistant to all five
classes of antibiotics.
Whole-genome sequences were obtained for the 32 selected
strains using Illumina technology and assembled into draft
genomes after read polishing. Genomes resulted to be of good
quality (average N50: 191,110; average number for contigs
above 500 bp = 116; average genome size (5,671,622 bp, see
Supplementary Table S2 for complete genome characteristics).
Genomes have been submitted to EMBL and are accessible
under accession PRJEB32609 (ERP115310). Genomes
were characterized by calculating the MLST, detecting
antibiotic resistance determinants and virulence factors (see
Supplementary Tables S3, S4 for complete results). The most
prevalent ST was ST258 (n = 19, 59.4%), followed by ST512
(n = 11, 34.4%). One isolate was found to belong to ST45 (3.1%).
One new ST was found, a single-locus variant (-SLV) of ST940
(genome 1998 from patient 5, now registered as ST3985). Among
the 5 patients with more than one isolate sequenced, one resulted
to be colonized by isolates of different STs (patients 5).
Results of the antibiotic resistance factors analysis
(Supplementary Table S3) were grouped in 12 drug classes
according to the ARG-ANNOT database (Gupta et al., 2014),
with β-lactamases divided into the six Lahey classes (Bush
and Jacoby, 2010). All 32 analyzed isolates carried at least one
ESBL gene (3.1% CTX-M-15, 3.1% SHV-1, 87.5% SHV-11, 6.3%
SHV-12) and/or inhibitor-resistant β-lactamase genes (87.5%
TEM-54 and 3.1% TEM-122). All the isolates were confirmed to
be resistant to carbapenems (9.4% KPC-2 and 90.6% KPC-3).
Kleborate identified colistin resistance as truncation or loss
of mgrB gene in 20 isolates (62.5%), if less than 90% of the
reference gene was covered by sequencing reads. Manual analysis
allowed to detect the presence of an Insertion Sequence (IS5-like)
interrupting mgrB in two resistant isolates (1880 and 1753). The
interruption due to this mobile element has been previously
reported (Cannatelli et al., 2014). All the other resistant isolates,
belonging to cluster 3, exhibited a frameshift mutation in mgrB
due to a 10 nucleotide insertion in position 109 of the gene.
Presence of mcr genes was investigated with ResFinder, but they
were never detected. Colistin antibiogram and genomic data
resulted to be coherent for all clones, with two exceptions, clone
1760 indicated as resistant in Kleborate but resulting sensitive at
the microdilution test and clone 1870 resistant to the phenotypic
test but not to the genomic analysis.
Results of the virulence determinants presence show that only
4/32 strains (12.5%) contained the ybt locus, which encodes
the biosynthesis pathway of the siderophore yersiniabactin (Lam
et al., 2018). None of the strains were found to harbor other
siderophores (aerobactin and salmochelin were screened). All
the four ybt positive strains were isolated from surveillance
rectal swabs of different patients and were sporadic cases.
Two of them (genomes 1758 and 1760) showed ybt allele 13,
carried by integrative conjugative element: ICEKp 2. The other
two isolates (genomes 1826 and 1998) showed respectively the
variants: ybt 10 (carried by ICEKp 4) and ybt 4 (plasmid-borne
allele). The association between the mobile genetic elements
found and the allelic variants of ybt gene is in agreement
with previous observations (Lam et al., 2018). The biosynthetic
pathway for the production of the toxin colibactin, as well as
the virulence factor rmpA/rmpA2 (responsible for the expression
of the hypermucose-viscous phenotype) were absent from all
32 strains. Finally, using the Kleborate tool we identified three
distinct K-loci. The most common K-locus was KL107 (n = 28,
90.3%), followed by KL106 (n = 2, 6.5%) and KL24 (n = 1,
3.2%). As expected from the literature (Shu et al., 2009), they
were found to be associated with wzi alleles 154, 29, and 101,
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TABLE 2 | Description of the 32 Klebsiella pneumoniae KPC isolates selected for the genomic characterization.
Genome ID Patient number Sample date Sample type Sequence type KPC-type
1753 1 June 02, 2015 rectal swab ST512 KPC-3
1758 2 June 23, 2015 rectal swab ST258 KPC-2
1760 4 June 29, 2015 rectal swab ST258 KPC-2
1826 3 August 11, 2015 rectal swab ST45 KPC-2
1845 5 September 01, 2015 rectal swab ST512 KPC-3
1870 5 September 14, 2015 wound swab ST512 KPC-3
1873 5 August 31, 2015 blood ST512 KPC-3
1880 6 September 15, 2015 rectal swab ST512 KPC-3
1897 7 October 08, 2015 rectal swab ST512 KPC-3
1935 8 October 26, 2015 bronchial aspirate ST512 KPC-3
1955 9 November 10, 2015 rectal swab ST512 KPC-3
1961 10 November 17, 2015 rectal swab ST512 KPC-3
1987 11 December 01, 2015 rectal swab ST258 KPC-3
1998 5 December 01, 2015 rectal swab ST3985 KPC-3
2003 12 December 08, 2015 rectal swab ST258 KPC-3
2018 12 December 29, 2015 bronchial aspirate ST258 KPC-3
2066 13 January 15, 2016 bronchial aspirate ST258 KPC-3
2079 16 January 26, 2016 rectal swab ST258 KPC-3
2106 5 February 02, 2016 rectal swab ST512 KPC-3
2110 14 February 02, 2016 rectal swab ST258 KPC-3
2133 17 February 16, 2016 rectal swab ST258 KPC-3
2137 16 February 07, 2016 blood ST258 KPC-3
2165 19 March 01, 2016 bronchial aspirate ST258 KPC-3
2174 19 March 14, 2016 blood ST258 KPC-3
2176 20 March 08, 2016 rectal swab ST258 KPC-3
2182 18 March 15, 2016 rectal swab ST258 KPC-3
2183 15 March 15, 2016 rectal swab ST258 KPC-3
2186 16 March 19, 2016 wound swab ST258 KPC-3
2205 22 April 04, 2016 rectal swab ST512 KPC-3
2218 23 April 19, 2016 rectal swab ST258 KPC-3
2221 21 April 19, 2016 rectal swab ST258 KPC-3
2228 21 April 24, 2016 blood ST258 KPC-3
respectively. K-locus was not typable for one isolate (1998) (see
Supplementary Table S4 for full results).
The distribution of the coreSNPs distances among the 32
sequenced genomes was calculated and plotted to determine a
threshold cut-off indicating epidemiological relatedness. A clear
threshold was detected at 16 coreSNPs (Figure 2), allowing
to determine the presence of three clades of genomes. Within
each clade, all genomes have reciprocal coreSNP distances lower
than the calculated threshold. A global coreSNPs maximum-
likelihood phylogeny was performed, including the 32 genomes
investigated in this work and 172 related genomes extracted
from the PATRIC database, in order to contextualize our
strains within the surrounding Kp diversity. The genomes
with coreSNPs distance below the threshold clustered in three
monophyletic clades (Figure 3 for the cladogram, see also
Supplementary Figure S1 that shows subtrees of the three
clusters) and were thus considered part of three separate
outbreak clusters (green, red, and violet clusters in Figures 3,
4). Five of the other six genomes do not cluster with
other genomes of the outbreak and are thus considered
sporadic cases. The last remaining genome (2205) is the
phylogenetic sister group of cluster 2, but presents a relatively
high number of coreSNPs with the other genomes of the
cluster (average 42 coreSNPs), and was thus considered as a
separate, sporadic, case.
Comparative genomic analyses were performed within the
three clades and to compare them to their nearest neighbor,
showing very limited genomic variation. No recombination was
detected at the origin of any of the three epidemic clades
(Supplementary Figure S2). IS content of isolates of each of the
three outbreaking clusters was compared using ISfinder. The IS
content resulted to be stable within each cluster, while each cluster
appears to have more ISs than the evolutionary closest sporadic
isolates. Specifically, isolates of Cluster 1 have IS of families ISL3
and IS1 that are absent in the sporadic sister group. Isolates
of cluster 2 present IS66 sequences, absent in the evolutionary
closest sporadic isolate. Isolates of cluster 2 are also richer in ISL3
and IS6 sequences than their neighbor and those of cluster 3 are
richer in IS5 and IS6. It must be noted however that the accuracy,
especially quantitatively, of such an analysis on draft genomes
is limited, due to the difficulties in assemblying IS sequences
(Supplementary Figure S3).
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FIGURE 3 | Phylogenetic tree based on coreSNPs from 32 Klebsiella pneumoniae KPC strains isolated from the Intensive Care Unit and 172 related genomes
retrieved from the PATRIC database. Sporadic strains are highlighted in blue; in green, red, and violet are the genomes belonging to three monophyletic clusters
(distance in SNPs < 16).
FIGURE 4 | Timeline of the presence of carbapenem-resistant Klebsiella pneumoniae positive patients in the ICU in the period from June 2015 to May 2016. The
periods of hospitalization are colored in gray. The other colors identify the sequenced samples based on genomic characterization. The colors green, red, and violet
correspond to the three clusters identified based on SNPs distance, are reported sporadic cases in blue. Samples obtained from clinical infections (not surveillance
swabs) are indicated by stars. The crosses indicate patients death. Black circles indicate the first positive CRKP rectal swab for each patient, negative at the
admission. Black triangles indicate the first positive CRKP rectal swab for patients already CRKP-colonized at the admission time into the hospital. Black diamonds
indicated the patients that became positive in other hospital wards.
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DISCUSSION
Here we present the results of the integrated characterization of
the CRKP strains isolated during a 1-year period (10 months
outbreak plus 2 months before) in the cardio-respiratory ICU of
the San Matteo hospital in Pavia, Northern Italy. Retrospectively,
starting in August 2015, we observed a strong increase in
CRKP isolated from routine surveillance rectal swabs, taken
from each ICU patient every week indicating a high number
of colonized patients. We also observed an increase in CRKP
isolations from clinical samples, indicating overt infections. This
trend continued until June 2016, with a total of 23 colonized
patients, among which 11 infected, prompting the investigation
presented here. Antibiotic resistance characterization coupled
with genome sequencing of 32 isolates from these 23 patients
(Table 2), collected in the outbreak period and in the 2 months
before, allowed the characterization of the extended outbreak.
Most strains were found to belong to CG258, one of the most
widespread KPC-bearing group in Italy and worldwide (Gaiarsa
et al., 2015; Onori et al., 2015).
Performing a SNPs distance analysis (Figure 1) we found
that twenty-six of the 32 isolates resulted to belong to three
genome clusters (coreSNPs < 16) that appeared in the ICU,
infected multiple patients, and then disappeared, with one
single strain lasting for most of the event (Figure 4, see
also Supplementary Figure S1 for phylogenetic reconstructions
of the three clusters). The remaining six genomes resulted
to be unrelated and were consequently classified as sporadic
isolates, as they all showed more than 35 coreSNPs with all
the other analyzed genomes. This result is coherent with a
recent multicenter study that proposed to set a threshold for
SNPs distance in Kp outbreak at 21 (David et al., 2019).
Interestingly, four of the six sporadic isolates represent the
strains characterized in the 2 months before the outbreak (June–
August 2015, see Figure 4), indicating that multiple strains
were present in the ICU, but they were only responsible for
colonization, did not cause clinical infections, nor they spread
to multiple patients. The six sporadic isolates are characterized
by variable levels of antibiotic resistance (number of resistance
classes determined with Kleborate ranging from 3 to 11). Two
of them are resistant to colistin (genomes ID: 1753, 1760). In
terms of virulence, the only isolates that present yersiniabactin
are four of the six sporadic isolates, all isolated from colonized,
not infected, patients. Most sporadic isolates belong to the CG258
(n = 4), one belongs to ST45, already reported as a KPC-bearing
strain in Italy (Cristina et al., 2016), and the final one to a
novel ST, variant of ST940, now classified as ST3985. These
sporadic isolates could be epidemiologically important, acting
as a “reservoir” for the spread of the mobile element carrying
blaKPC.
The strain responsible for the first cluster of isolations,
belonging to ST512, was isolated from patient 5 from a screening
sample in August 2015 and then from clinical samples in
September. The patient remained colonized until his death in
March. The isolates of this cluster are characterized by the
resistance to 10 antibiotic classes, remaining susceptible to
colistin, with two exceptions. The first one (genome ID: 1880) is
the only strain of the cluster, belonging to patient 6, which present
a correspondence between phenotypic (MIC > 64 mg/L) and
genotypic (loss/truncation of mgrB gene) colistin resistance. The
other colistin-resistant strain of the cluster (genome ID: 1870)
was the third of four in the temporal series isolated from patient
5 and resulted phenotypically colistin-resistant (MIC = 4 mg/L),
even though no colistin-resistance mutation/gene was detected
in the genome. In order to investigate the presence of other
mutations potentially causing colistin resistance, the genomes
of the isolates belonging to patient 5 were manually examined,
detecting 2 SNPs unique to the colistin-resistant isolate. These
SNPs are co-localized in an intergenic region upstream of the pca
operon, potentially responsible for the β-ketoadipate pathway.
Understanding whether these SNPs could be related to colistin
resistance would require additional investigations.
One additional CRKP was isolated from patient 5 on
December 1st. This isolate was unrelated to those of cluster 1,
belonging to ST3985 (a novel SLV of ST940). In order to evaluate
whether this strain acquired the KPC plasmid from the ST512
strain co-present in patient 5, we compared the contigs harboring
the KPC gene, performing a phylogenetic analysis including
contigs from isolates of cluster 1, from the ST3985, and from
another sporadic isolate (1753), as control. We found that the
KPC-harboring contig from the ST3985 was divergent from all
identical contigs retrieved from the ST512 isolates belonging to
cluster 1, but also from the sporadic control, which resulted sister
group of the isolates of the cluster (Supplementary Figure S4).
Four isolates were grouped in cluster 2, belonging again to
ST512. This clone was short-lived but was transmitted from
patient 7 to three other patients in the course of 6 weeks and
caused one clinical infection. The isolates of this cluster are
resistant to most antibiotics, retaining susceptibility to colistin
and tigecycline. Two of four isolates resulted phenotypically
sensitive to aminoglycosides, while genome analysis are only in
partial agreement, indicating that all four strains carry the aph3-
Ia gene, which should confer resistance to this class of antibiotics.
The largest of the clusters is represented by 17 strains, isolated
from 12 patients during 5 months, causing five clinical infections
and resulting in three deaths. The isolates of this cluster are
those characterized by the highest level of resistance, retaining
susceptibility only to tigecycline. Genomic analysis agrees with
this result indicating the presence of resistance genes against 11
antibiotic classes, one more than the two other clusters. Indeed,
all the isolates of this cluster resulted resistant to colistin with
phenotypic tests, and the analysis of the genome content using
Kleborate highlighted a possible resistance-causing truncation in
the mgrB gene in all 17 strains. Manual analysis allowed to detect
a frameshift mutation in mgrB due to a ten nucleotide insertion
in position 109 of the gene.
CONCLUSION
Over the course of 1 year, nine different strains of Carbapenem
resistant K. pneumoniae were isolated in the ICU from 23
patients, 12 only colonized, 11 infected. Three strains colonized
multiple patients, were the cause of all the seven clinical
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infections reported in the ICU in this period and were responsible
for the outbreak that lasted for 10 months. The three outbreaking
strains did not present more virulence genes than the six sporadic
isolates, four of which were actually the only ones exhibiting
yersiniabactin. In terms of antibiotic resistance, both outbreaking
and sporadic strains were phenotypically resistant to most classes,
a result confirmed by strong repertoires of resistance genes.
A clear correlation between antibiotic resistance profiles and
number of colonizations or infections is thus not clearly evident.
Our results highlight the importance of the overall environmental
context, possibly more than the intrinsic characteristics of a
strain, in determining the spread of different CRKP isolates.
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